The scar treatment market size was around USD 14.25 Billion in 2022 and is projected to reach USD 32.52 Billion by 2031, expanding at a CAGR of 9.6% during the forecast period, 2023 – 2031. The growth of the market is attributed to the rising demand for rejuvenating the skin and enhancing visual attractiveness in individuals.
The body creates scars as a natural means of repairing and replacing lost or damaged skin. In most cases, fibrous tissue makes up scars. Numerous reasons, including infections, surgeries, wounds, and tissue inflammation, results in the formation of scars. Topical treatments, such as creams and lotions, are used to treat the scars. Scars may also be treated with laser therapy using pulsed dye lasers and CO2 lasers. The prevalence of various scar types, such as stretch marks, keloid scars, hypertrophic scars, and atrophic scars, is a major factor driving the scar treatment market. In order to make these scars less noticeable and more in line with the surrounding skin tone and texture, therapy and revision techniques are used.
COVID-19 Impact on Scar Treatment Market
In all areas of the healthcare industry, telemedicine was rapidly adopted during the first two waves of the COVID-19 pandemic. Skincare is non-emergency thus, requires few hospital visits. The Covid-19 pandemic affected the demand and supply of scar treatment market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced to shut down production leading to an unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Scar Treatment Market Dynamics
The market research report on the global scar treatment market provides a detailed analysis by focusing on revenue growth, facts, figures, and historical data to determine major drivers, existing restraints, key opportunities, and competitive analysis. The report includes recent developments that can shape the overall performance of the market during the assessment period, 2023 to 2031.
Major Drivers
Rising cases of road accidents to boost the market
Increasing traffic accidents is of the key factors driving the market. According to the Population Reference Bureau, around 50 million individuals are wounded in car accidents each year, which usually results in scarring and requires surgical intervention. Patients who undergo these treatments also get surgical scars, which are treated with topical medications to reduce and improve their look. Growing number of road accidents along with rising cosmetic surgeries is anticipated to drive the market.
Growing prevalence of skin diseases is fueling the market
The prevalence of skin disorders such as photoaging, vitiligo, eczema, psoriasis, and is rising as a result of excessive exposure to pollutants and ultraviolet (UV) radiation, which causes sunburns, decreased skin flexibility, and hair loss. Without correct and timely treatment for these disorders, results in scarring. Other skin conditions that can result in scarring include stretch marks brought on by pregnancy or weight changes, post-surgical scars, burns, and acne. Acne is the most prevalent dermatological problem in the world, affecting the majority of people, and eventually resulting in scars. These factors are estimated to drive the scar treatment market.
Existing Restraints
High cost of the treatment to impede the market growth
High cost of the treatment is projected to hinder the market growth during the forecast period. According to the American Society of Plastic Surgeons, an ablative laser treatment typically costs USD 2,071 whereas a non-ablative laser procedure typically costs USD 1,144. Laser skin resurfacing includes scar removal. Additionally, scar therapy results in a number of consequences, which is also anticipated to restrain the scar treatment market. Complications include skin infections, redness, itching, and soreness which result from using the wrong dosage or medication.
Key Opportunities
Changing preference towards silicone-based treatment to create immense growth opportunities
Silicone-based treatment is a major trend observed in the scar treatment market because silicone-based products, such as gels and gel sheets, are successful at fading scars, and cosmetic surgeons & medical professionals all over the world recommend them. The effects of silicone gels, which are applied to the skin last for 24 hours. There are various silicone-based scar removal solutions available in the market, such as Xeragel, ScarAway & Kelo-cote scar gel, and Avosil scar care ointment. Silicone-based solutions are effective for healing scars and provide benefits including simple application, sun protection, and bacterial invasion prevention, which further increases consumer demand for such products.
Scope of Scar Treatment Market Report
The global scar treatment market research report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Scar Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023 – 2031
|
|
Segmentation
|
Scar Type (Stretch Marks, Contracture Scars, Hypertrophic and Keloid Scars, and Atrophic Scars), Product (Injectables, Laser Products [Pulse-dyed Laser, CO2 Laser, and Others], Topical Products [Silicon Sheets, Gels, Creams, and Others], Others), and End-user (Retail Pharmacies/ E-commerce, Clinics, and Hospitals)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Avita Medical Ltd.; Bausch Health Companies, Inc.; Candela Corp.; CCA Industries, Inc.; Cynosure; Enaltus LLC; Hologic, Inc.; Johnson & Johnson; Lumenis; Merz Pharmaceuticals, LLC; Mölnlycke Health Care AB; Newmedical Technology Inc.; Pacific World Corporation; Perrigo Company plc.; Quantum, Inc.; Revitol Corp.; Scar Heal Inc.; Scarguard Labs, LLC; SkinCeuticals; Smith & Nephew PLC; Sonoma Pharmaceuticals, Inc.; and Suneva Medical
|
Scar Treatment Market Segment Insights
The atrophic scars segment accounted for a key market share in 2021
Based on scar type, the market is segregated into stretch marks, contracture scars, hypertrophic and keloid scars, and atrophic scars. The atrophic scars segment accounted for a key market share of around 37% in 2021 owing increasing prevalence of acne scars. Atrophic scars are typically caused by the body losing muscle and fat where an injury has occurred. Atrophic scars typically develop when the skin does not create enough collagen to heal the infection site. This type of pit-like scar is generally brought caused by chicken pox, staphylococcus infections, acne, and in certain circumstances, surgery. Topical lotions and gels are typically used to treat these scars, which are readily available. The procedure used to repair these scars stimulate the skin's normal healing process, which helps to replenish collagen, elastin, and other fibrous structures. The need for such topical medicines to treat atrophic scars is rising due to the rising need for cosmetic appeal.
The topical products segment held around 60% of the total market share in 2021
On the basis of product, the market is fragmented into injectables, laser products, topical products, and others. The laser products segment is further segregated into pulse-dyed laser, co2 laser, and others. The topical products segment is sub-fragmented into silicon sheets, gels, creams, and others. Silicone sheets, creams, and topical gels are sold as over-the-counter (OTC) items, making it possible for anyone to heal scars. Additionally, using these goods for therapy eliminates the need for patients to visit hospitals for medicine, making it an easy alternative that is anticipated to increase demand for these items. Other topical products include ointments, sprays, oils, and elastic bandages. In order to treat scars, pressure garments put pressure on the affected area. These do not require surgery and are simple to apply at home without a doctor's help. However, these topical medicines are less effective and need to be used consistently for about 6 to 12 months noticeable changes, which is expected to hinder the market growth.
The laser segment is estimated to expand at a rapid pace during the forecast period. The most recent and advanced technology for treating scars is laser therapy. Moreover, laser scar therapy is painless, non-invasive, and delivers results right away with no discomfort.
The hospitals segment to expand at a high CAGR during the forecast period
In terms of end-user, the market is divided into retail pharmacies/ e-commerce, clinics, and hospitals. The hospitals segment accounted for a key market share of around 45% in 2021. Growth of the segment is attributed to the use of sophisticated infrastructure and the availability of technologically advanced products. The majority of scar therapy is provided at hospitals, where patients can select from a variety of methods to minimize or remove the scar.
Most of the time, hospitals deal with cuts and wounds, burn injuries, and other severe injuries before providing patients with further emergency care. Large hospitals frequently use a variety of sophisticated tools and scientifically complex practices for patient treatment. In hospitals, laser therapy is combined with the use of noninvasive methods including silicone sheets, lotions, and gels. The majority of emergency care services are provided by hospitals, which also give further care during the recovery period.
North America dominated the market in 2021
Based on region, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021 due to rising aesthetic awareness among consumers and the adoption of advanced products. In 2020, the U.S. accounted for the key market share in North America. The American Burn Association (ABA) estimates that 486,000 burn cases occur each year. Scar due to burn injuries is covered under government reimbursement regulations in the United States. Rising patient healthcare expenditures in North America are one of the key factors driving the market. Presence of key market players such as Scar Heal, Inc., CCA Industries, Inc., Cynosure, Inc., and Sonoma Pharmaceuticals in the region is expected to fuel the market.
Asia Pacific is anticipated to expand at a high CAGR during the forecast period owing to rising cases of road accidents in countries such as China and Japan. Most of the countries in this region have emerging economies and are rapidly adopting new technologies. Rising R&D investments made by large multinational corporations in these nations are a key factor boosting the market in the region.
Segments
The global scar treatment market has been segmented on the basis of
Scar Type
- Stretch Marks
- Contracture Scars
- Hypertrophic & Keloid Scars
- Atrophic Scars
Product
- Injectables
- Laser Products
- Pulse-dyed Laser
- CO2 Laser
- Others
- Topical Products
- Silicon Sheets
- Gels
- Creams
- Others
- Others
End-user
- Retail Pharmacies/ E-commerce
- Clinics
- Hospitals
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Avita Medical Ltd.
- Bausch Health Companies, Inc.
- Candela Corp.
- CCA Industries, Inc.
- Cynosure
- Enaltus LLC
- Hologic, Inc.
- Johnson & Johnson
- Lumenis
- Merz Pharmaceuticals, LLC
- Mölnlycke Health Care AB
- Newmedical Technology Inc.
- Pacific World Corporation
- Perrigo Company plc.
- Quantum, Inc.
- Revitol Corp.
- Scar Heal Inc.
- Scarguard Labs, LLC
- SkinCeuticals
- Smith & Nephew PLC
- Sonoma Pharmaceuticals, Inc.
- Suneva Medical
Competitive Landscape
Key players competing in the scar treatment market include Avita Medical Ltd.; Bausch Health Companies, Inc.; Candela Corp.; CCA Industries, Inc.; Cynosure; Enaltus LLC; Hologic, Inc.; Johnson & Johnson; Lumenis; Merz Pharmaceuticals, LLC; Mölnlycke Health Care AB; Newmedical Technology Inc.; Pacific World Corporation; Perrigo Company plc.; Quantum, Inc.; Revitol Corp.; Scar Heal Inc.; Scarguard Labs, LLC; SkinCeuticals; Smith & Nephew PLC; Sonoma Pharmaceuticals, Inc.; and Suneva Medical. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
-
In September 2021, SkinCeuticals, a medical skincare brand introduced an advanced Scar Control. The unique semi-occlusive procedure helps to enhance the appearance of fresh scars by shielding delicate skin.
-
In April 2021, Pharmaxis, an Australia-based pharmaceutical research company partnered with the University of Western Australia. This partnership's objective was to launch a clinical trial to look into a cream that can prevent scarring after trauma, notably for burn injuries.
Request For Customization
Enquiry Before Buying
Speak With Analyst
